Imaging is paramount to the diagnosis and management of ischemic stroke, offering a battery of structural and functional probes of cerebrovascular physiology. The technical underpinnings of stroke imaging continue to evolve, bringing the neuroscience community increasingly closer to high-resolution, tissue-level biomarkers of brain perfusion, metabolism, and viability. The rapid expansion of neuroimaging in this domain has met with controversies, and in many respects, a lack of generalizable conclusions regarding optimized use in cerebrovascular disease. This review aims to provide the reader with the depth and scope of both established and emerging techniques, and an overview of prevailing viewpoints regarding neuroimaging in acute ischemic stroke.
scenario, this review will focus principally on the imaging of acute ischemic brain infarction. A standardized approach to imaging selection and interpretation will be emphasized, underscoring (1) modality selection; (2) technical elements of CT and MRI approaches to neurovascular imaging; (3) the staging of brain ischemia; and (4) advanced brain imaging for prognostication and treatment selection in acute stroke patients. Where possible, relevant patient-specific factors and hardware demands will be discussed, with the objective of facilitating communication and optimizing imaging utilization in such patients.
Stroke carries considerable societal burden, affecting nearly 795 000 individuals annually in the USA alone. While stroke-related deaths have fallen in recent years, placing stroke now fifth among the leading causes of death, recent statistics still attribute approximately 1/20 deaths in the USA to stroke, claiming 1 life every 4 min. 1 Imaging has become critical to the initial evaluation of the acute stroke patient, permitting for the initial and timely distinction of hemorrhagic vs the more common ischemic causes of stroke. Clinical decision making is bolstered by the use of imaging in such patients, among whom clinical stroke mimics may complicate management, accounting for up to 19% of patients initially diagnosed, and up to 14% of patients initially treated for acute stroke. 2, 3 The sensitivity of imaging for detection of acute ischemic stroke (AIS) can, however, vary considerably, depending primarily on the imaging modality used as well as the timing of imaging relative to ischemic onset.
PATHOPHYSIOLOGY OF AIS
The pathophysiological cascade in AIS reflects primarily a failure in the delivery of oxygen and glucose, and the removal of metabolic waste. The critical dependence of brain function on steady, nutritive flow and bound oxygen hinges on the energetic advantage of oxidative metabolism in the brain, producing greater than 10× ATP for cellular metabolism by comparison to glucose alone. 4 The extremely limited concentration of dissolved tissue oxygen is however insufficient to meet these needs for more than short durations, driving neuronal vulnerability to hemodynamic compromise.
Mean cerebral blood flow (CBF), reflecting blood flow normalized to tissue volume (ie, perfusion), is normally approximately 50 to 55 mL/100 g tissue/min, 5 varies markedly with neural activity, and differs between normal gray and white matter, where perfusion is halved. 6 Within physiological ranges, the brain responds remarkably to falling upstream perfusion pressure, and its impact on mean capillary transit time (MTT), by the recruitment of increasing cerebral blood volume (CBV) modulated by arteriolar size and perhaps vascular resistance. [7] [8] [9] Under such feedback, flow relates intimately to tissue metabolism, and thus a generally uniform value of <50% is observed for the oxygen extraction fraction (OEF) from blood. Further drop in perfusion pressure demands ever-increasing arterial vasodilation and collateral recruitment to preserve flow as predicted through the central volume principle, applied here as CBF = CBV/MTT. 10, 11 Exhaustion of blood volume expansion, amid further falling perfusion pressure therefore leads to decreasing CBF, with a consequent increase in OEF to maintain cerebral oxygen metabolism and function. The increasing OEF may compensate for falling CBF in this regime; however, further decreases in CBF cannot be compensated sufficiently to sustain metabolic needs, and an initial phase of ischemia ensues. 8, 12, 13 While electrical activity ceases almost immediately following arterial occlusion in experimental models, more gradual functional deterioration and electrical slowing can be observed at comparatively modest hypoperfusion (15-20 cc/100 g/min), producing a potentially detectable clinical deficit created by a reversible state of tissue hypoperfusion. This tenuous state of hypoperfusion renders such tissues effectively at risk, inasmuch as that they exist in a potentially reversible state of ischemia, provided that reperfusion (spontaneous or therapeutic) can occur in a timely manner, 12, 14 confirmed in a nonhuman primate model of middle cerebral artery (MCA) occlusion 15 and later investigations. 16 Hypoperfusion may be sustainable indefinitely, and without fully apparent clinical deficits, above approximately 20 cc/100 g/min, partially sustained via tissue-level collateral flow, perhaps from neighboring territories by leptomeningeal vascular recruitment. 13, 17, 18 In contrast, below a certain hypoperfusion threshold, perhaps 8 to 10 cc/100 g/min, irreversible injury (infarction) may develop relatively quickly. 12, 15 These observations led Astrup et al 14 to propose a paradigm for operationally defining ischemic tissue states in a seminal conceptual advancement coined the ischemic penumbra. Drawn from cosmology, the paradigm proposes a zonality to ischemic tissues, consisting of an inner core (umbra) of irreversibly infarcted tissues and a marginal zone (penumbra) of ischemic but viable tissues at risk of infarction in the absence of reperfusion. A remote periphery of tissues may be normal or maintained in a state of potentially benign oligemia, in which they may exist indefinitely without progression, although potentially in varying degrees of downregulation.
The ischemic penumbra paradigm allows conceptualization of a sequence of brain injury proceeding between 2 critical hypoperfusion thresholds: the first demarcating electrical (and thus functional) failure and a second heralding the onset of energetic and therefore ionic failure with membrane depolarization, culminating in cytotoxicity. 12, 19 We hasten to add that while certain pathophysiological features commonly exist within these tissue profiles, the penumbra paradigm is purely an operational construct for the description of ischemic zones, perhaps overly simplified and without functional or physicochemical certainty. [20] [21] [22] [23] The approach is nevertheless valuable, given that physical examination alone cannot discriminate between reversible and irreversible ischemia, or combinations thereof. Indeed, clinical stroke scales such as the National Institutes of Health Stroke Scale may be weighted to detect the overall burden of hypoperfusion, without the ability to further assess the relative volumes of infarcted vs penumbral tissues. 24, 25 Within hypoperfused tissues, the difference in flow between reversible and irreversible tissues may be vanishingly small, depending on the duration of ischemia; the penumbra exists in a delicate and highly dynamic pathophysiological state at best defined only as a snapshot in time, and may therefore exist in a variegated preinfarction state. 19, 22 From a histopathological standpoint, individual regions may therefore not evolve homogeneously, and viable penumbral tissues may be present even 12 to 24 h or greater following acute symptom onset. [26] [27] [28] Of particular importance in the ischemia cascade is the shifting of water from the interstitial to the intracellular space, following sodium influx from failure of membrane potential. Far preceding the significant vasogenic edema and swelling that will later ensue, these water shifts and consequent cytotoxic edema can be interrogated with diffusion-weighted imaging (DWI), a specialized MRI sequence sensitized to the changing microscopic diffusion range of water molecules as they move from the facilitated interstitial compartment to the more hindered boundaries of the intracellular space, as detailed in the following section.
IMAGING APPROACHES TO THE ISCHEMIC STROKE PATIENT
Conventional imaging of AIS has historically consisted of CT or MRI, and in both cases the salient imaging features predominately reflect either changes in the bulk water content of tissue or the previously described shifts in the tissue water pool between extracellular and intracellular compartments (DWI). The former manifests primarily as hypoattenuation in CT, or areas of increased intensity in fluid-sensitive MRI sequences such of fast spin echo T2-weighted (T2) and fluid-attenuated inversion recovery (FLAIR)-T2 imaging.
This process of increasing tissue water content (i.e. vasogenic edema) primarily relates to transudation of fluid from the intravascular compartment and typically is limited in the early aftermath of ischemia, during which loss of cellular membrane potential leads to cytoxic edema following failure of Na + /K + -ATPase. As introduced above, it is this critical pathophysiological event to which DWI is sensitized in the earliest phases of infarction, [29] [30] [31] DWI sequences continue to undergo major technological advancements, and the sensitivity of DWI may vary in some settings or due to various technical factors which are discussed in detail in excellent resources on the topic (Figure 1 ). [32] [33] [34] Noncontrast CT (NCCT) has historically represented the initial imaging approach of choice, due to its nearly ubiquitous availability and acquisition speed, allowing for the rapid exclusion of intracranial hemorrhage and cursory characterization of the extent of infarcted tissue. Provided the absence of absolute contraindications to treatment, and the presence of relatively small infarctions (eg, less than one-third MCA territory), patients may then undergo intravenous (IV) administration of thrombolytics (primarily recombinant tissue plasminogen activator, tPA) if presenting within 3 to 4.5 h of known time of onset. NCCT may, however, be limited in its sensitivity (20%-75%) to injury in the early aftermath of ischemia, [35] [36] [37] [38] [39] in part related to a relatively high degree of inter-rater variability for detecting ischemic changes (eg, parenchymal hypoattenuation, loss of graywhite matter differentiation, and cortical swelling); 37, 38, 40 thus, in isolation NCCT may be insufficient to characterize the tissue state for a subset of patients presenting beyond the IV tPA window, and in whom more aggressive endovascular approaches (eg, intra-arterial tPA, clot retrieval) may be beneficial. In such patients, conventions for characterizing early ischemia on NCCT (see below) may be complemented by more advanced approaches to (1) identify large vessel thromboembolism by CT angiography (CTA) or (2) predict reversible and irreversible ischemic volumes by CT perfusion (CTP). The use of advanced CT imaging in this setting may increase imaging time and, importantly, iodinated contrast and radiation exposure. Specifically, the stochastic risks of ionizing radiation exposure (particularly in women), the possible potentiation of ischemia due to oxidative stress induced by ionizing radiation, and contraindications to nephrotoxic iodinated contrast agents are all reported risks when undertaking CTA/CTP. 41 CTP imaging is nevertheless in widespread use, notwithstanding mixed acceptance, with recent and emerging evidence suggesting a potentially valuable role in patient selection. 41, 42 MRI has been alternatively proposed in this setting, although cost and historically limited availability were thought to engender diagnostic and treatment delays, and therefore potential impediments to its use. While now far more widely available in the acute setting, at the time of this writing such factors remain potential concerns in the stroke neuroscience and imaging community. 41 Despite such limitations, MRI remains the relative standard for the identification of irreversibly infarcted tissue, based on identification of abnormally reduced microscopic Brownian motion of water by DWI allowing for the detection of the early cytotoxic edema inherent to central nervous system (CNS) ischemia. 29, 31, 43 Existing paradigms for the safe and optimal use of imaging in acute stroke are continually challenged, and local practices may vary considerably. Imaging approaches must continue to weigh the relative benefits of speed and availability vs accuracy and sophistication, and to this end the following sections aim to provide the reader with a comprehensive overview of acute stroke imaging, review of the pathophysiological underpinning of cerebrovascular ischemia.
Imaging Evolution of AIS
The evolution of brain infarction by imaging may only partially parallel the histopathological chronology, and definitions of infarction phases may therefore differ. However, it is the opinion of the authors that chronological definitions in AIS are most reproducibly defined by the generally predictable imaging milestones representing the acute, subacute, and chronic changes of infarctions. The expected imaging progression nevertheless represents only a general set of guidelines, and not immutable principles; however, significant deviation from the expected chronology should at minimum alert the examiner to the potential for alternative diagnoses.
In the earliest phases of hypoperfusion, tissue diffusivity as identified from computed diffusion maps known as apparent diffusion coefficient (ADC) can be observed to decrease dynamically. ADC maps represent a valuable adjunct in the characterization of DWI, due to confounding effects of relative T2 contrast in the latter. Specifically, high and low signal regions in DWI, despite its diffusion weighting, may actually relate to prolongation (T2 shine through) and shortening (T2 blackout) of tissue T2 relaxation, respectively. Removal of these T2 contrast contributions in ADC therefore allow for more confident and quantitative characterization of acute tissue ischemia, which manifests as high intensity voxels on DWI and low intensity voxels in ADC maps.
The initial reduction in ADC, which may occur within minutes following ischemic injury, may be transient and below the threshold for infarction ( Figure 2 ). For this reason, recent trials have advocated for the use of ADC thresholds (eg, <620 × 10 -6 cm 2 /s) for more quantitative assessment of irreversible injury, although such thresholds are neither entirely sensitive nor specific. In this light, the occasionally encountered reports of "reversible" DWI abnormalities, sometimes observed with transient or mild clinical symptoms, may thereby reflect subthreshold diffusion reduction (manifesting as subtle signal abnormalities in DWI and ADC). Similar observations have been reported by the DEFUSE investigators in early (spontaneous or therapeutic) reperfusion of the diffusion abnormality, so-called "RADARS". Occasionally early reperfusion of even infarcted voxels may cause pseudonormalization, due to intravoxel averaging of vasogenic and cytoxic edema, with their opposing effects negating the diffusion abnormality. It is worthwhile to point out that DWI infarction thresholds may lack uniformity between subjects, and even within the brain of a single subject, reflecting a differential vulnerability between tissues, such as that related to the greater metabolic demands of gray matter.
Initially, following infarction the capillary endothelium and therefore the blood-brain barrier (BBB) remain intact, protected by their relative immunity to ischemic injury by comparison to neuronal substrate. [44] [45] [46] Generally, within 6 h of ischemia, the integrity of the BBB is compromised, potentially continuing for 
FIGURE 2. DWI and ADC reversibility and infarction thresholds. A 94-year-old woman presented with transient right-sided weakness and dysarthria. Presentation NCCT (not shown) was normal. MRI and DSC MRP demonstrated vague, focal high intensity in the left corona radiata, not reaching a priori assigned diffusivity threshold of 620 cm 2 /s on DWI (arrow, A) and ADC (arrow, B) images. DSC perfusion Tmax maps C revealed hypoperfusion throughout the left MCA territory, although thresholded Tmax maps (not shown) indicated delays of less than 6 s through much of the affected territory, suggesting potentially benign oligemic delay. CTA obtained during admission demonstrated high-grade M1 steno-occlusive disease (arrow, D). The patient's symptoms soon resolved, and medical management was optimized. Three weeks following initial presentation, recrudescence of symptoms occurred, and repeat MRI at that time demonstrated definitive acute cytoxic injury E, F suggesting hyperacute injury in the region of previously reversible ischemia. Such reversible DWI and ADC changes are occasionally observed in transient cerebrovascular ischemia.
days before transient normalization. 44, 47, 48 Tissue enhancement during this acute stage is generally not captured by imaging, due in some cases to insufficient delivery of IV contrast agents beyond vascular occlusion. As an exception, contrast staining may sometimes be observed in highly acute infarctions following endovascular reperfusion, manifesting as high attenuation on CT, or enhancement on gadolinium-enhanced T1-weighed images. Discriminating such contrast staining from hemorrhagic transformation can be difficult; however, marked hyperattenuation (eg, exceeding 120 HU) allows more confident determination of contrast staining. Often the 2 coexist, and follow-up CT may be contributory in documenting early contrast wash out in the following days, while hemorrhage may persist for days and weeks. 41 More recently, the use of dual-energy CT scanning, prescribed for instance at 80 and 140 KV (potentially at no radiation penalty), has been reported as potentially permitting for correct assignment of hemorrhage versus iodinated contrast, and recent evidence suggests that such differentiation correlates with the 3-month outcome. 49, 50 The implications of discriminating between the 2 remain controversial, although correct determination may help inform anticoagulant selection following stroke or arterial stent placement. 51, 52 Later within the acute phase of infarction, following disruption of the BBB, vasogenic edema ensues with macromolecules and water filling the extravascular, extracellular compartment. [53] [54] [55] [56] The development of significant vasogenic edema may in part be dependent on the presence of some residual/collateral flow, and may be particularly severe with reperfusion, particularly in the setting of luxury perfusion, in which paradoxically increased CBF is delivered to injured tissues lacking autoregulation. 45, 56 This increase in tissue water content, compared with the minor 3% to 5% increase occurring during the initial cytotoxic phase, increases the detectability of infarctions on fluid-sensitive MRI techniques (T2 and T2-FLAIR) and subsequently NCCT. 44, [54] [55] [56] Within the initial 4 h, only 30% to 50% of AIS demonstrate abnormalities on FLAIR, typically cortical swelling and high intensity, while at 7 h most strokes are detectable. 46 Occasionally, preceding high intensity on T2-WI, white matter may exhibit a paradoxical mild decrease in signal, possibly related to slow flow with accumulation of paramagnetic deoxyhemoglobin and free radicals. 46 Slow flow of surface leptomeningeal vascularity may also cause signal changes, manifesting as high signal on T2-FLAIR and postcontrast T1-weighted images. Occasionally, loss of expected arterial flow voids on precontrast and postcontrast T1-weighted images may be observed.
By comparison with T2-FLAIR, NCCT is less sensitive to early vasogenic edema, and may remain subtle or negative in infarcted regions even at 6 h. CT changes are driven by the inverse correlation of X-ray attenuation with brain water content, and have been quantified in animal stroke models producing an approximately 2 HU decline for every 1% increase in tissue water content. 53, 56 However, detection of these minor changes may not be possible within the limits of CT contrast resolution and the limits of the human eye (approximately 4 HU). [54] [55] [56] Further complicating the use of CT, mild sulcal effacement, if related to increasing tissue blood volume, may prove reversible with reperfusion. [54] [55] [56] Nevertheless, narrow gray scale contrast windows are necessary to optimize identification of the subtle loss in graywhite matter interface as seen in the insular ribbon and lentiform nuclei following MCA occlusion.
Barber et al 57 have attempted to formalize the approach to characterization of early CT signs of infarction in the Alberta Stroke Program Early CT Score (ASPECTS), deducting a point for each of 10 supratentorial regions exhibiting hypoattenuation/swelling: 7 regions at the ganglionic axial level and 3 cortical regions at the level of the periventricular white matter. More recently, recognition that isolated sulcal effacement without hypoattenuation may reflect reversible ischemia has met with modifications to ASPECTS, and interpreters should be cautious of overestimating infarctions on the basis of this finding alone.
While commonly employed, it is the opinion of the authors that the use of ASPECTS alone may be insufficiently sensitive to characterize the tissue state in the early phases of ischemia; however, at present its use is supported by expert consensus as a potential methodology to identify favorable endovascular treatment candidates. The hyperacute CT changes described in animal models may not be readily detectable in practice, and the overwhelming majority of ischemic tissues visible to the human eye are irreversible. 41 The inferior performance of ASPECTS in predicting clinical and radiographic outcomes as compared with competing methodologies using CTP has been reported, highlighting the potentially large range of infarcted and atrisk tissues corresponding to individual ASPECTS. 58, 59 Nevertheless, the superiority of different imaging-based approaches for patient selection remains inconclusive, and the subject of ongoing inquiry. 60 Paralleling the development of visible injury in T2 and T2-FLAIR (and hypoattenuation on CT), an interesting phenomenon may be observed on computed ADC maps. Because the spatial scale of a voxel is considerably larger than that of individual tissue diffusion compartments (up to a million neurons per cubic millimeter of voxel), a given voxel may volume average multiple intravoxel tissue compartments confounding interpretation. Consequently, areas of acute cytotoxic injury (low ADC) may be averaged with the developing vasogenic edema occupying the extravascular, extracellular space with its high ADC, therefore producing potentially pseudonormalized average values. In practice, this early ADC pseudonormalization is unlikely to complicate interpretation, given that the clinical scenario is often suggestive, and that DWI images remain distinctly high in signal, sometimes even becoming brighter due to the summative effects of high signal from cytotoxic injury combined with the contributions of vasogenic edema to T2 contrast in the image. Pseudonormalization on ADC may, however, occasionally prove problematic if very small strokes on DWI are interrogated, such that assessing the ADC and therefore the chronicity of the lesion can be difficult to establish. In this setting, the examiner can confidently characterize the lesion as, at most, a recent infarction with pseudonormalization, provided that the ADC is not definitively high as expected in a more subacute-chronic injury. Importantly, high signal on T2 and T2-FLAIR does not, in itself, imply that a lesion cannot be acute, given the potential detectability on such fluid sensitive sequences as early as 4 to 6 h. Accordingly, the so-called DWI-FLAIR mismatch (hyperintense on DWI, normal on T2-FLAIR) has been proposed to identify hyperacute lesions when the time of onset is unknown, such as in the setting of wake-up stroke. However, the utility and overall accuracy of this approach remain unestablished. 61 As vasogenic edema begins to peak over the course of several days, higher intensities on DWI may develop. With further evolution beyond this period of greatest edema, however, slow pseudonormalization of signals on DWI may be detected as described earlier in ADC, due to intravoxel averaging of decreased and increased diffusion compartments. During the late acute phases of infarction, a process of pseudonormalization may occur in CT as well, described as a fogging of the infarction, either diffusely obscuring it or occasionally affecting the cortex disproportionately. [62] [63] [64] The latter may present a potential pitfall whereby the combined gray and white matter involvement expected in large vessel infarctions is instead replaced by hypoattenuation isolated to the white matter, potentially mimicking vasogenic edema such as may be seen with neoplasia or inflammatory disorders ( Figure 3) .
As the infarction further progresses toward the subacute stage, potentially beginning within a week of injury, swelling will begin to subside, although increased signal on T2-weighted imaging and FLAIR persists. The reparative tissues laid down within the infarction bed may lack a well-formed BBB, and it is at this juncture that gyral enhancement characteristic of the subacute phase is more commonly encountered (Figure 4) .
When a preceding history of infarction is unknown, the presence of either gyral or focal (in the setting of lacunar injury) enhancement without associated mass effect may suggest the presence of a subacute infarction, particularly when confined to a vascular territory. Ultimately, the coexistence of enhancement and diffusion reduction should alert the interpreter to potential etiologies other than bland ischemia, 45 including encephalitides, infective embolic infarctions, or less commonly hypercellular tumors. In such cases, a short-interval follow-up is recommended to ensure expected evolution/resolution. 54 Occasionally enhancement and reduced diffusion may coexist such as in cases of early reperfusion (see above), or when temporally heterogeneous ischemic injury is present such as at the arterial border zones of cerebral circulation in patients with chronic arterial steno-occlusive disease and recurrent ischemic injury ( Figure 5 ).
The chronic stage of ischemic injury may ensue variably following the subacute stage, wherein enhancement may continue for up to several months before restoration of the BBB. 41 The high signal on T2-weighted imaging can generally be expected to persist indefinitely within the infarcted tissue, although in occasional cases, regions of cystic encephalomalacia may demonstrate signal suppression on T2-FLAIR. 46 Very small, chronic infarctions may sometimes prove difficult to detect, even by MRI. However, lacunar infarctions will commonly exhibit a rim of gliosis surrounding central regions of CSF signal on all pulse sequences that typically allow for their differentiation from prominent perivascular spaces. Related abnormalities accompanying the former will occasionally be encountered such as transneuronal degeneration of white matter tracts, crossed cerebellar diaschisis, or hypertrophic olivary degeneration. 41 
Perfusion Imaging in AIS Perfusion Imaging Using Exogenous Contrast Agents
Various approaches to patient selection exist, with the goal of extending the therapeutic window beyond the limited 3 to 4.5 h window, which constrains the use of IV tPA. 42, [65] [66] [67] [68] Patients presenting beyond this time frame, those with an unknown time of onset, and those without a significant improvement in deficits following IV tPA all present a challenging clinical scenario. Specifically, the risks of intra-arterial intervention, including those inherent to peripheral and delicate cerebrovascular manipulation, potential high doses of iodinated contrast and radiation, use of anesthesia, and the critical possibility of treatment futility or catastrophic hemorrhage must be weighed. 23, 60, 69 The therapeutic benefit of intra-arterial revascularization was brought into question in a series of randomized controlled trials failing to demonstrate definitive benefit in AIS, [70] [71] [72] although device selection, operator expertise, and appropriate patient selection may have impacted the potential for trial success. 73 More recent, advanced endovascular stent-retriever devices have significantly improved the likelihood of rapid revascularization; however, it is on the subject of patient selection that imaging plays a central role. [74] [75] [76] The primary goals of imaging include not only the exclusion of hemorrhage and the detection of an offending clot, but also an important assessment of the tissue state to inform the potential for tissue salvage vs treatment futility.
The evolution of brain injury in the early aftermath of ischemia may not be spatially homogeneous, and at any moment in time a combination of dead, ischemic but viable, and normal or stable tissues may coexist. It is in this regime of acute ischemia that decisions for aggressive therapeutic maneuvers may be informed by advanced imaging techniques such as CTP or MR perfusion (MRP) to subselect target patients for therapy. 42, 65, 66 The logical step of characterizing the ischemic penumbra paradigm was first pursued by Schlaug et al 41 using specific signatures derived from MRI dynamic susceptibility contrast (DSC) perfusion imaging. A commonly employed approach then emerged in acute stroke imaging, in which the infarction core is predicted from reductions in CBV or CBF (either qualitative or semiquantitatively) using CTP or using DWI or ADC in MRI. These core predictions are then coupled with estimates of the total volume of hypoperfused tissues as approximated from an imaging time domain parameter such as time-to-peak (TTP), time-to-maximum of the tissue residue function (Tmax), or MTT. 77, 78 The mathematical derivation of these parameters leverages dynamic bolus passage kinetics using iodine (CT) or an off-label use of gadolinium (MRI) for nondiffusible tracers, modeled from the indicator dilution theory and central volume principle, 41 and excellent reviews are available for the interested reader. [79] [80] [81] The use of perfusion parameters in CTP or contrast-enhanced MRP should be recognized as fundamentally qualitative or at best semiquantitative at present, and appropriately used as relative values (eg, rCBF, rCBV), as compared with contralateral normal tissues. In practice, when using CTP for estimation of the ischemic core, a qualitative assessment of the rCBV maps, appropriately windowed to accentuate the normal gray-white matter interface, is suggested. Our suggested approach would be to focus one's assessment primarily on the cortical and deep gray matter, given that the blood volume of the white matter is sufficiently low at baseline as to complicate accurate determination of diminished CBV within the signal-noise limits of most CTP. The optimal determination of ischemic core remains a matter of controversy in CTP, as more advanced, automated systems have supplanted CBV with CBF (eg, thresholded at <30% of contralateral tissues) for core estimation, as used in recent trials due to its greater accuracy. 82 However, the use of CBF for core estimations cannot be reliably employed when purely subjective, qualitative approaches to analysis are undertaken, given that CBF may visibly fall within clearly viable tissues. The use of CBF therefore currently requires thresholding relative to a normalized value such as the contralateral tissues.
In contrast to CTP, MRP benefits from the complement of DWI, which obviates the need for use of CBV or CBF as a surrogate to predict infarction core. In MRI, a qualitative determination of the overall hypoperfusion volume on, for example, Tmax will then permit for estimation of the penumbra as the ratio of the abnormality on Tmax relative to the volume of infarcted tissues on DWI or ADC. 41 Tmax has widely replaced MTT as the parameter of choice for determination of overall hypoperfusion in most contemporary stroke perfusion trials, given its more straightforward determination, higher lesion to background contrast, relatively flat gray-white matter contrast, greater accuracy in the setting of bolus truncation from poor cardiac output, and the greater ease of quantitative thresholding for automated analysis systems and lesion segmentation. 41 In the absence of specialized software needed to perform the necessary mathematical deconvolution to isolate Tmax, MTT and TTP can be used alternatively, recognizing the potential vulnerabilities inherent to each.
The use of exogenous contrast-based perfusion imaging in outcome prediction and patient selection have been reported, including the DEFUSE trial, which employed MRP to identify 
Postcontrast T1-weighted images C demonstrate atypical coexistence of enhancing regions intermixed among regions of reduced diffusion, raising the possibility of encephalitic injury or infective emboli in this immunosuppressed patient. Cervical MR angiogram (not shown) demonstrated a moderate left cervical carotid stenosis, favoring the coexistence of acute (reduced diffusion) and sub-acute (enhancing) border zone injury, and short interval follow-up examination was advised to ensure expected evolution. Follow-up MRI demonstrates resolution of reduced diffusion (DWI and ADC; D, E) and enhancement (not shown), with the development of border zone encephalomalacia and gliosis on T2-FLAIR F.
patients most likely to benefit from intravenous reperfusion. 41 As an extension, the DEFUSE2 trial tested the hypothesis that prespecified diffusion-perfusion mismatch profiles can identify patients likely to benefit from endovascular therapy, and from these trials a target mismatch profile emerged, defined by relatively small infarction cores, and large volumes of at-risk tissue. 41 These observations could not initially be reproduced in the multicenter EPITHET trial, which investigated the use of alteplase beyond 3 h using imaging selection; however, technical limitations were identified, and following reanalysis, positive results were reported post hoc. 83, 84 Criticisms of perfusion-based selection include the possibility that viable treatment candidates may be excluded by overly conservative target mismatch profiles, and recent studies have reported efficacy in reperfusion of large core patients with large mismatches, as well as octogenarians among other traditionally excluded demographic cohorts. 85, 86 The successful use of CTP as an alternative to MRI was more recently reported in the multicenter SWIFT-PRIME and EXTEND IA trials, taking advantage of more advanced contemporary stent-retriever technology and perfusion imaging selection. 42, 87 Informed by earlier analysis of the DEFUSE2 and EPITHET trial populations, the CTP in these studies was analyzed using a user-and vendor-independent, automated postprocessing software environment for semiquantitative infarction core and penumbral estimation. 58, 88 The hypoperfused tissues were thus defined as regions of Tmax >6 s and infarct core defined as rCBF <30% relative to the contralateral normal CBF. However, the optimum thresholds for Tmax and rCBF remain a subject of ongoing investigation, and specific values may vary depending on the goals or imaging (Figures 6  and 7) . 23, 58 While CTP and MRP have been utilized in patient selection, as above, other approaches to risk stratification and patient selection exist, and the optimal strategy remains to be conclusively established. For example, recent trials have variably employed CT-and CTA-based strategies, including varying approaches to prediction such as ASPECTS, and any of several CTA collateral scores. 67, 68 Advantages to all approaches are well recognized and local practice paradigms often guide stroke imaging triage. Recent studies have highlighted the potential advantages of advanced, perfusion-based techniques, particularly autothresholded and segmented pipelines of tissue analysis as utilized in the SWIFT-PRIME trial, over more qualitative techniques such as ASPECTS and collateral score; however, imaging selection remains to be prospectively studied in the randomized setting. 59 Lastly, aggressive endovascular management of AIS has reminded the medical community that revascularization may not equate to successful reperfusion at the tissue level. 89, 90 The topic of infarct progression despite reperfusion has confirmed the need to ensure that full reperfusion is achieved following thrombolysis either via perfusion or dedicated catheter angiographic imaging approaches (Figure 8) . 65, 66, 91 Intraoperative catheter arteriographic scales (eg, TICI and modified (m)TICI-thrombolysis in cerebrovascular ischemia scales) aim to better address tissue level perfusion following endovascular therapy, recognizing that further comparative study remains warranted.
42,66

Noncontrast Perfusion Imaging Techniques
In recent years, several provocative studies have reported the deposition of dechelated gadolinium in key structures within the human brain (globus pallidus and dentate nuclei), albeit of unknown significance at present. [92] [93] [94] [95] [96] [97] Nonetheless, the implications for potential gadolinium deposition in neuronal tissue invite interest in alternative methods to assess cerebrovascular perfusion that would obviate the need for intravascular injection of an exogenous contrast agent. This is additionally true for patients with nephrogenic systemic fibrosis, impaired renal function, and those with an increased risk for possible allergic contrast reaction.
Arterial spin labeling (ASL) is an MRP sequence that assesses CBF without the use of an injected contrast agent or ionizing radiation. 41 It can typically be performed in 5 min, is infinitely repeatable, and approaches a truly quantitative measure of absolute CBF (in mL/100 g tissue/min) that is less dependent on relative estimations of perfusion.
98-101 ASL does not use any exogenous contrast agent, making it advantageous for imaging pediatric patients or subjects with difficult IV access. 41 Instead, the ASL sequence uses unique radiofrequency excitation pulses that magnetically "label" water protons in the blood en route to the brain, while passing through the neck arteries. The magnetization (label) is detected for some time (limited by the T1 decay of blood) as the blood travels to the brain, is transferred to the brain parenchyma via capillary exchange at a rate that is dependent on tissue perfusion, and is ultimately detected by the MR system. Such attributes favor use of ASL for perfusion imaging longitudinally, or across experimental conditions, such as prior to, and following pharmaceutical or other hemodynamic maneuvers ( Figure 9 ).
The reproducibility of CBF quantification by ASL has been demonstrated in multicenter studies, 102, 103 and the ASL sequences are now commercially available on all major MRI vendor platforms. Most importantly, the accuracy of ASL in measuring CBF has been validated in human subjects against CBF reference methods including 15O-labeled water positron emission tomography 104, 105 and technetium 99mTc-D, L-hexamethylpropyleneamine oxime single-photon emission CT, 41 as well as stable xenon CT. 100,106 ASL MRI therefore offers an accurate, direct measure of global brain parenchymal perfusion, less influenced by pathological variability in integrity of the BBB 41 given the nearly free diffusion of tagged blood water across aquaporin channels.
Initial studies suggest that ASL is a powerful tool in evaluating several intracranial cerebrovascular pathologies, including transient ischemic attack 41 and AIS. 107 In AIS, for example, a focus of curvilinear bright signal can be observed on raw ASL data images and can be used to identify the level of vascular occlusion, [108] [109] [110] as demonstrated in Figure 10 . This figure also highlights the potential for ASL in the detection of collateral vessels manifesting as arterial transit artifact (ATA) 106 in AIS. 111, 112 Hyperperfusion detected by ASL may serve as a noninvasive imaging biomarker for prediction of postischemic hemorrhagic transformation in AIS, 113 with an odds ratio of 3.5 at any of the investigated time points, illustrated in Figure 11 .
Direct comparison between ASL and DSC PWI has been largely favorable, with several groups reporting similar identification of penumbra using ASL. 107, 114, 115 One such study by Bivard et al 41 suggested that an ASL-CBF threshold of 40% revealed the highest area under the curve (AUC = 0.76) in detecting the acute penumbra in patients with AIS, defined by the corresponding DWI obtained at 24 h in nonreperfused patients. This was similar to the AUC obtained with a DSC-based Tmax >6 s penumbral threshold (AUC = 0.79) and a CTP-Tmax > 5.5 s penumbral threshold (AUC = 0.77). Such reports support the general trend for greater incorporation of ASL as a noninvasive method to assess cerebrovascular perfusion; however, its full integration in standard clinical practice has met with delay due to technical concerns detailed subsequently. 
Collateral Evaluation with ASL
The identification of ATAs has been previously associated with collateral vascular supply in prior studies. 106, 116 More recently, Lyu et al 117 evaluated the ability of ASL to appropriately identify antegrade and collateral flow using a 2-delay postlabel delay pseudocontinuous ASL technique, compared with catheter angiography as the reference standard. While this was a small study (21 patients with available comparative conventional angiography), the authors reported a Spearman correlation coefficient of 0.81 between collateral grade and late-arriving retrograde ASL flow proportion (P < .0001), suggesting that this may be an appropriate method to evaluate collaterals in patients with unilateral MCA stenosis. 41 
Limitations and Strengths of ASL
Currently, ASL suffers well-recognized limitations that can be particularly problematic in AIS, and includes (1) relatively poor signal-to-noise ratio (compared with DSC PWI), (2) underdeveloped assessment of CBV, and (3) currently longer acquisition times than its DSC counterpart. Alterations in arterial arrival time (especially delays) can challenge accurate CBF quantification. 41 However, several solutions have been suggested, including in the setting of AIS, to improve CBF quantification. 114, [118] [119] [120] In addition, any derived, quantitative CBF values should always be corrected for gender-, age-, and subjectdependent mean cerebral perfusion. 121 Ironically, it is these latter "shortcomings" that simultaneously allow for intra-and intersubject comparison of quantitative regional CBF values over time. A recent consensus paper on the ASL technique can provide the reader with an excellent synopsis of clinical applicability and sequence optimization. 41 The limitless repeatability of ASL could potentially allow for a paradigm shift in the evaluation of AIS, particularly with respect to therapeutic efficacy. One study, for example, performed serial ASL imaging in patients with AIS and monitored the development of ATA during active thrombolysis, reporting that the simultaneous development of ATA during treatment was associated with early reperfusion following therapy. 122 In this way, ASL could be used to potentially guide similar therapeutic strategies in AIS, beyond the current treatment paradigm.
CONCLUSION
The imaging of stroke and neurovascular disease continues to evolve, with ongoing expansion of the technical armamentarium at use for the characterization of tissue viability, perfusion, and metabolism. The historic approach to characterizing CNS structure has thus been supplanted, or complemented, by enhanced characterization of CNS function, much as our understanding of structural connectivity is now bolstered by a framework for understanding functional connectivity.
Imaging has repeatedly proven essential to the growing knowledge of neurovascular diseases, and in varying degrees remains elemental to diagnosis, prognostication, and treatment selection and monitoring in this domain. The use of imaging biomarkers to predict salvageable penumbral tissue in the setting of AIS has steadily increased, albeit with mixed acceptance. The balance of fast but potentially imprecise or rudimentary approaches to neuroimaging triage vs the use of more sophisticated, but time-consuming functional, pathophysiological imaging biomarkers remain contentious and lacking in generalizable conclusions. Both approaches deserve merit and could be conceivably complementary; in the view of some, the notion that "time equals brain" invites the most streamlined, efficacious, and reproducible approach, with recognition of pragmatism, although a more fluid approach recognizing that a physiological rather than temporal approach better reflects the target population for treatment garners growing support in this era of contemporary endovascular technology. This is further compounded by the unclear role that collateral vasculature and ischemic preconditioning or neuroprotection may play in inviting or obviating the need for catheter-based intervention, and how they may modify the therapeutic window. In either case, the continued study of these factors is deeply entrenched within the scientific agenda of the stroke neuroscience community.
In closing, advantages to both CT and MR approaches discussed above are recognized and may have a prominent role in the management of AIS, based on local practice paradigms, expertise, and scanner availability. Imaging of AIS, like the underlying pathophysiology, is a dynamic process, and it is the hope of the authors that this work will serve as a helpful guide in the management of AIS for the immediate future, recognizing that continuing studies and incorporated knowledge may render this review obsolete in the years to come.
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